Covance, a leading drug development partner for pharmaceutical and biotech companies, called on Coyne PR to support their thought leadership and marketplace positioning. The agency activated around each of Covance’s foundational business groups including: nutritional chemistry and food safety; discovery; preclinical; clinical; and post-marketing medication safety work for companies such as Lilly, Sanofi, Merck and Takeda. We worked with the global corporate communications team to highlight the increased return on clinical trial investment, which led to numerous feature stories in vertical pharma, research and manufacturing trade media.